GPT HEALTHCARE Latest Share Price (GPTHEALTH)
TODAY IN ONE LINE
GPTHEALTH fell 1.2% on average volume, in line with Nifty's -0.3% move.
With a market cap of ₹1,298.11 Cr., it trades at a P/E of 27.90. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
GPT HEALTHCARE flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 13.7% YoY
- ●High Capital EfficiencyROCE of 17.3% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 15.7%
- ●High Promoter HoldingPromoters hold 65.6% skin-in-the-game
- ●Steady Dividend YieldReliable 1.58% dividend yield
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.06x
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Sales ContractionQuarterly sales dropped 0.1% YoY
Latest GPT HEALTHCARE News
What changed recently?
Recent events, corporate actions, and announcements.
GPT HEALTHCARE valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for GPT HEALTHCARE, framed against the sector median so the premium or discount is obvious at a glance.
GPT HEALTHCARE trades at a P/E of 27.90× and P/B of 4.89×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
GPT HEALTHCARE technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for GPT HEALTHCARE — derived from the latest tape, not yesterday's close.
GPT HEALTHCARE last traded at ₹159.38 with an intraday range of ₹157.12–₹161.2 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹159.38| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 169.51 | +10.13 | +6.35% |
| R3 | 165.43 | +6.05 | +3.79% |
| R2 | 163.31 | +3.93 | +2.47% |
| R1 | 161.35 | +1.97 | +1.23% |
| PIVOT | 159.23 | -0.15 | -0.09% |
| CURRENT | 159.38 | — | — |
| S1 | 157.27 | -2.11 | -1.33% |
| S2 | 155.15 | -4.23 | -2.65% |
| S3 | 153.19 | -6.19 | -3.89% |
| S4 | 149.11 | -10.27 | -6.45% |
GPTHEALTH is trading Above CPR, indicating Bullishness
CPR is Narrower, suggesting likely for trending moves
Day's range: ₹157.12–₹161.2
Trading Below opening range, showing Bearishness
GPT HEALTHCARE financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for GPT HEALTHCARE — consolidated or standalone — with margins, YoY growth and key ratios inline.
GPT HEALTHCARE reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,298.11 Cr. and reported EPS of ₹1.55.
GPT HEALTHCARE segment analysis : revenue and profit mix.
Disclosed business segments at GPT HEALTHCARE with their share of revenue and profit, switchable between consolidated and standalone reporting.
GPT HEALTHCARE discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for GPT HEALTHCARE.
Our AI distills the core fundamental drivers supporting GPT HEALTHCARE, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
GPT HEALTHCARE's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
ROCE 20.57% significantly exceeds peer median, demonstrating superior capital efficiency.
Negligible debt-to-equity ratio 0.0006x provides substantial financial flexibility and stability.
Operating margin 13.34% TTM supports healthy profitability in competitive healthcare sector.
ROE 15.67% with stable promoter holding 65.57% aligns management with shareholders.
TTM EPS grew 13.7% YoY, demonstrating underlying earnings momentum despite recent softness.
Key Risks.
Latest quarterly EPS declined 12.6% YoY, signaling operational headwinds in recent period.
Net profit fell 15.4% YoY to ₹42.22 Cr, indicating margin compression.
FII holdings eased from 6.68% to 3.20%, signals foreign investor caution on stock.
DII holdings fell from 11.61% to 6.45% QoQ, reduced domestic institutional confidence.
High capex ₹261.62 Cr in latest quarter strains free cash flow generation capacity.
Flip Conditions.
Valuation risk. a P/E above 36 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 11% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 0.79%.
GPT HEALTHCARE peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — GPT HEALTHCARE is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
GPT HEALTHCARE chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for GPT HEALTHCARE — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
GPT HEALTHCARE delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for GPT HEALTHCARE over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in GPT HEALTHCARE stood at 55.1% of traded volume, against a 20-day average of 56.4%.
GPT HEALTHCARE announcements: results, concalls, ratings, M&A.
Filings GPT HEALTHCARE sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
GPT HEALTHCARE files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 81 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
GPT Healthcare Limited has informed the Exchange about Transcript
Shareholders meeting
GPT Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 06, 2026. Further, the company…
Shareholders meeting
GPT Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 06, 2026
Analysts/Institutional Investor Meet/Con. Call Updates
GPT Healthcare Limited has informed the Exchange about Link of Recording
Copy of Newspaper Publication
GPT Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
Investor decks & rating reports.
GPT HEALTHCARE dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue GPT HEALTHCARE has declared, sequenced by announce and record date.
GPT HEALTHCARE corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About GPT HEALTHCARE: business, sector, key facts.
What GPT HEALTHCARE does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
GPT HEALTHCARE operates in the Hospital industry under the Healthcare sector, listed as NSE: GPTHEALTH, BSE: 544131.
GPTHEALTH, operating under the ILS Hospitals brand, is a significant healthcare provider in India. Its core business centers around a network of multispecialty hospitals offering a comprehensive range of medical services. This expansive portfolio allows them to cater to a wide patient demographic and a broad spectrum of health needs.
The company's medical services are extensive, encompassing a wide array of specialties. These include internal medicine and diabetology for managing chronic conditions; nephrology, with a focus on advanced procedures like renal transplants; surgical expertise covering laparoscopic, general, and specialized areas such as bariatric and metabolic surgery; women's health services encompassing gynecology and obstetrics; and critical care services within their emergency departments.
Further specializations within GPTHEALTH's hospital network include gastroenterology for digestive health; orthopedics and joint replacement surgery; interventional cardiology for heart-related procedures; neurosciences for neurological conditions; pediatric and neonatal care; and urology. The incorporation of robotic procedures signifies a commitment to utilizing advanced technology for improved precision and minimally invasive surgical options.
Beyond its hospital network, GPTHEALTH extends its reach through ancillary services. These include the operation of clinics and pharmacies, providing convenient access to primary care and medication. The company also participates in academic endeavors and provides diagnostic services, enhancing its comprehensive approach to patient care. An unusual aspect of their operations involves the sale of power, suggesting a possible internal power generation capability supporting hospital operations or a separate revenue stream.
Established in 1989 and headquartered in Kolkata, India, GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd. Its long history and diversified services position it as a substantial player in the Indian healthcare landscape, indicating a commitment to long-term growth and development within the sector.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- DR AGARWALS HEALTH CARE L (AGARWALEYE) Share PricePeer
- APOLLO HOSPITALS ENTER L (APOLLOHOSP) Share PricePeer
- ARTEMIS MED SERVICE (ARTEMISMED) Share PricePeer
- ASTER DM QUALITY CARE (ASTERDM) Share PricePeer
- FORTIS HEALTHCARE (FORTIS) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about GPT HEALTHCARE (GPTHEALTH).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of GPT HEALTHCARE (GPTHEALTH)?
The current share price of GPT HEALTHCARE (GPTHEALTH) is ₹159.38. Today, the stock has declined by ₹1.91 (1.18%), trading in a range of ₹157.12 to ₹161.20. The stock opened at ₹161.00 with a trading volume of 97,541 shares.
02Is GPT HEALTHCARE stock a good investment for long-term?
GPT HEALTHCARE can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,298.11 Cr., P/E ratio of 27.9, ROE of 15.67%, and ROCE of 17.26%. The dividend yield stands at 1.58%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of GPT HEALTHCARE stock?
The 52-week high price of GPT HEALTHCARE (GPTHEALTH) is ₹175.00, while the 52-week low is ₹115.00. Currently trading at ₹159.38, the stock is 38.59% above its 52-week low and 8.93% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy GPT HEALTHCARE stock at the current price?
Whether to buy GPT HEALTHCARE stock at ₹159.38 depends on multiple factors. The stock is currently trading with a P/E ratio of 27.9 and P/B ratio of 4.89. Today's performance shows a loss of 1.18%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of GPT HEALTHCARE and when is the next dividend?
GPT HEALTHCARE offers a dividend yield of 1.58%, which means for every ₹100 invested at the current price of ₹159.38, you can expect to receive approximately ₹1.58 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of GPT HEALTHCARE?
GPT HEALTHCARE's key financial metrics include: P/E Ratio: 27.9, P/B Ratio: 4.89, ROE: 15.67%, ROCE: 17.26%, Dividend Yield: 1.58%, EPS: ₹1.55, Book Value: ₹32.84, and Debt-to-Equity: 0.06. The company's market cap stands at ₹1,298.11 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is GPT HEALTHCARE stock performing today in the market?
GPT HEALTHCARE stock opened at ₹161.00 and is currently trading at ₹159.38, showing a decline of ₹1.91 (1.18%). The intraday high is ₹161.20 and low is ₹157.12. The trading volume stands at 97,541 shares, indicating moderate market participation today.
08What is the P/E ratio of GPT HEALTHCARE and what does it indicate?
GPT HEALTHCARE has a Price-to-Earnings (P/E) ratio of 27.9, which means investors are willing to pay 27.90 for every ₹1 of earnings. With an EPS of ₹1.55, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about GPT HEALTHCARE (GPTHEALTH) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.